Loading...
Carfilzomib
India Pharmaceutical Trade Intelligence
Who Supplies Carfilzomib to India from CANADA
India's carfilzomib imports from CANADA total $518.8K across 17 shipments from 6 foreign suppliers. ADIRAMEDICA INC leads with $449.4K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include DR.REDDY'S LABORATORIES LTD. This corridor reflects India's pharmaceutical import demand for carfilzomib — a diversified sourcing base with multiple active suppliers from CANADA.
Top foreign suppliers (CANADA) — Ranked by import value
ADIRAMEDICA INC is the leading Carfilzomib supplier from CANADA to India, with import value of $449.4K across 3 shipments. The top 5 suppliers — ADIRAMEDICA INC, M/S. DELUXE HEALTH GROUP INC., ESPEE PHARMA CANADA INC., ACCORD HEALTHCARE INC, GLOBYZ PHARMA — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (CANADA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ADIRAMEDICA INC | $449.4K | 3 | 86.6% |
| 2 | M/S. DELUXE HEALTH GROUP INC. | $25.4K | 1 | 4.9% |
| 3 | ESPEE PHARMA CANADA INC. | $16.9K | 1 | 3.3% |
| 4 | ACCORD HEALTHCARE INC | $14.8K | 6 | 2.9% |
| 5 | GLOBYZ PHARMA | $12.2K | 3 | 2.4% |
| 6 | SANDOZ CANADA INC | $91 | 3 | 0.0% |
Showing top 6 of 6 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from CANADA)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | DR.REDDY'S LABORATORIES LTD | $466.3K | 4 | 89.9% |
| 2 | NATCO PHARMA LIMITED | $25.4K | 1 | 4.9% |
| 3 | INTAS PHARMACEUTICALS LIMITED | $14.8K | 6 | 2.9% |
| 4 | GLENMARK PHARMACEUTICALS LIMITED | $12.2K | 3 | 2.4% |
| 5 | MSN LABORATORIES PRIVATE LIMITED | $91 | 3 | 0.0% |
Import Statistics
- Import Value
- $518.8K
- Shipments
- 17
- Foreign Suppliers
- 6
- Indian Buyers
- 5
- Avg. Shipment
- $30.5K
Other Carfilzomib Import Origins
Related Analysis
Frequently Asked Questions — Carfilzomib Imports from CANADA
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Carfilzomib suppliers from CANADA to India?
The top Carfilzomib suppliers from CANADA to India include ADIRAMEDICA INC, M/S. DELUXE HEALTH GROUP INC., ESPEE PHARMA CANADA INC.. The leading supplier is ADIRAMEDICA INC with import value of $449.4K USD across 3 shipments. India imported Carfilzomib worth $518.8K USD from CANADA in total across 17 shipments.
QHow much Carfilzomib does India import from CANADA?
India imported Carfilzomib worth $518.8K USD from CANADA across 17 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Carfilzomib from CANADA?
The main Indian buyers of Carfilzomib sourced from CANADA include DR.REDDY'S LABORATORIES LTD, NATCO PHARMA LIMITED, INTAS PHARMACEUTICALS LIMITED. The largest buyer is DR.REDDY'S LABORATORIES LTD with $466.3K in imports across 4 shipments.
QWhat is the total value of Carfilzomib imports from CANADA to India?
The total value of Carfilzomib imports from CANADA to India is $518.8K USD, across 17 shipments and 6 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: CANADA to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Carfilzomib.
- 2.Supplier/Buyer Matching: 6 foreign suppliers from CANADA and 5 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $518.8K aggregated from 17 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
17 Verified Shipments
6 suppliers, 5 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists